Tizanidine
- Product NDC
- 52959-689
- 11-digit product format
- 529590689
- Labeler code
- 52959
- Product ID
- 52959-689_efa8102d-2da1-4d92-b884-fd9c8bd80383
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tizanidine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- H.J. Harkins Company, Inc.
- Application
- ANDA076286
- Marketing category
- ANDA
- Marketing start
- 2002-07-03
- Marketing end
- 0000-00-00
- Substance
- TIZANIDINE HYDROCHLORIDE
- Active strength
- 4 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- E
- Listing certified through
- 2018-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 52959-689 | TIZANIDINE TABLET [H.J. HARKINS COMPANY, INC.] | 3 | Legacy NDC, 12 package rows | 20111222_6d8e0262-5ccf-4447-90dd-f5eec069664c.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 52959-689-02 | 52959068902 | 120 in 1 BOTTLE | Historical |
| 52959-689-05 | 52959068905 | 150 in 1 BOTTLE | Historical |
| 52959-689-08 | 52959068908 | 180 in 1 BOTTLE | Historical |
| 52959-689-15 | 52959068915 | 15 in 1 BOTTLE | Historical |
| 52959-689-20 | 52959068920 | 20 in 1 BOTTLE | Historical |
| 52959-689-21 | 52959068921 | 21 in 1 BOTTLE | Historical |
| 52959-689-30 | 52959068930 | 30 in 1 BOTTLE | Historical |
| 52959-689-42 | 52959068942 | 42 in 1 BOTTLE | Historical |
| 52959-689-45 | 52959068945 | 45 in 1 BOTTLE | Historical |
| 52959-689-60 | 52959068960 | 60 in 1 BOTTLE | Historical |
| 52959-689-63 | 52959068963 | 63 in 1 BOTTLE | Historical |
| 52959-689-90 | 52959068990 | 90 in 1 BOTTLE | Historical |